King Abdullah University of Science and Technology

Dana Alhattab

Charlotte A E Hauser

Manola Moretti

Hepi Hari Susapto

Panagiotis Bilalis

Salwa Alshehri

Hattan Boshah

Kowther Kahin

Ali Aldoukhi

Hamed Albalawi

Alexander Valle Perez

Zainab Khan

Rosario Perez Pedroza

Abdulelah Alrashoudi

The present disclosure relates a method of fabricating a literal flow immunoassay (LFIA) for the diagnosis of diseases, including COVID-19. The present disclosure further relates to a fusion-epitopes peptide that can be used in the LFIA test to improve sensitivity, specificity and accuracy of the test.

Developing lateral flow immunochromatography (LFIA) peptide-based test strips for rapid detection of antigens and antibodies against specific antigens

The present disclosure relates to a coaxial nozzle for building a 3D tissue model. Accordingly, a nozzle for 3D tissue bioprinting may include at least one buffer solution inlet, at least one peptide inlet, at least one cell inlet, and a mixing chamber. The least one buffer solution inlet is attached to the at least one peptide inlet. The at least one cell inlet is attached to the at least one peptide inlet. The at least one buffer solution inlet may be attached from a side of the at least one peptide inlet, and the at least one cell inlet may be disposed externally and attached at an angle to the at least one peptide inlet.

Nozzle for 3D bioprinting

Growing community of inventors

Thuwal, Saudi Arabia

Dana Alhattab